KCM
BIIB icon

Kornitzer Capital Management’s Biogen BIIB Stock Holding History

Kornitzer Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,075
Closed -$537K – 473
2023
Q4 		$537K Buy
2,075
+625
+43% +$154K 0.01% 430
2023
Q3 		$373K Buy
+1,450
New +$388K 0.01% 461
2020
Q4 		– Sell
-2,000
Closed -$567K – 490
2020
Q3 		$567K Hold
2,000
– – 0.01% 450
2020
Q2 		$535K Hold
2,000
– – 0.01% 455
2020
Q1 		$633K Hold
2,000
– – 0.02% 424
2019
Q4 		$593K Sell
2,000
-11,326
-85% -$3.14M 0.01% 453
2019
Q3 		$3.1M Sell
13,326
-1,050
-7% -$244K 0.06% 297
2019
Q2 		$3.36M Sell
14,376
-531
-4% -$123K 0.06% 285
2019
Q1 		$3.52M Sell
14,907
-105
-0.7% -$33.1K 0.06% 275
2018
Q4 		$4.52M Sell
15,012
-5
-0% -$1.6K 0.09% 241
2018
Q3 		$5.31M Sell
15,017
-615
-4% -$212K 0.08% 242
2018
Q2 		$4.54M Sell
15,632
-15,978
-51% -$4.49M 0.08% 247
2018
Q1 		$8.65M Buy
31,610
+240
+0.8% +$74.5K 0.15% 192
2017
Q4 		$9.99M Sell
31,370
-3,680
-10% -$1.18M 0.17% 172
2017
Q3 		$11M Sell
35,050
-3,935
-10% -$1.17M 0.19% 161
2017
Q2 		$10.6M Sell
38,985
-1,905
-5% -$504K 0.19% 167
2017
Q1 		$11.2M Buy
40,890
+545
+1% +$154K 0.2% 158
2016
Q4 		$11.4M Sell
40,345
-97
-0.2% -$28.8K 0.21% 149
2016
Q3 		$12.7M Buy
40,442
+30
+0.1% +$8.88K 0.23% 157
2016
Q2 		$9.77M Sell
40,412
-1,815
-4% -$478K 0.18% 182
2016
Q1 		$11M Buy
42,227
+1,715
+4% +$453K 0.19% 176
2015
Q4 		$12.4M Buy
40,512
+5,882
+17% +$1.69M 0.2% 174
2015
Q3 		$10.1M Buy
34,630
+22,202
+179% +$7.33M 0.16% 192
2015
Q2 		$5.02M Buy
12,428
+3,849
+45% +$1.54M 0.07% 263
2015
Q1 		$3.62M Sell
8,579
-14,105
-62% -$5.56M 0.04% 281
2014
Q4 		$7.7M Buy
+22,684
New +$7.34M 0.09% 223

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kornitzer Capital Management's BIIB Position: Q1 2024 in Review

Kornitzer Capital Management sold out of Biogen (BIIB) in Q1 2024, closing a stake of 2,075 shares — an estimated $537K sold.

Kornitzer Capital Management first reported a position in BIIB in Q4 2014 and held it in 26 quarters. The position peaked at $12.7M in Q3 2016. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Kornitzer Capital Management reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Kornitzer Capital Management sold 2,075 Biogen shares in Q1 2024, an estimated $537K.
  • Kornitzer Capital Management first reported a position in Biogen in Q4 2014 and held it in 26 quarters.
  • Kornitzer Capital Management's Biogen position peaked at $12.7M in Q3 2016.
  • 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Kornitzer Capital Management's 13F filing for Q1 2024, filed 2 May 2024.